Is intermediate radiation dose escalation with concurrent chemotherapy for stage III non-small-cell lung cancer beneficial? A multi-institutional propensity score matched analysis
Project objectives
Evaluating the impact of dose escalation in the treatment of locally advanced non-small cell lung cancers
Start and end date
2014 - 2015
Project Manager
prof Sara Ramella
Coordinating institution of the project
London Health Sciences Center - London, Ontario, Canada
Other Institutions involved in the project
- MAASTRO Clinic - Maastricht, The Netherlands
- VU University Medical Center - Amsterdam, The Netherlands
- Hyogo Cancer Center - Akashi, Japan
- Universidad de Navarra - Pamplona, Spain
- National Cancer Center - Goyang-si, Gyeonggi, Korea
- University of North Carolina - Chapel Hill, North Carolina
- University of Washingtonington - Seattle, Washington
- Karolinska University Hospital - Stockholm, Sweden
- Ghent University - Ghent, Belgium
- Universidad Pompeu Fabra - Barcelona, Spain
- London Health Sciences Center - London, Ontario, Canada
- washington University School of Medicine - St. Louis, Missouri